Thank you Wall for sharing your expertise and experience.
to a layperson like myself, it is a bit unnerving to see how these reviews are conducted and ultimately decided...compared to the apparent level of rigor that the trial results and stats analysis are subjected to before it gets to the public testimony stage.
thank God for Dr. Mule asking that the FDA clarify the efficacy question and ultimately for the CTGT & not ODAC holding the AC meeting.
just a guess, but it seems to me if this panel had been convened by pazdur & ODAC, it might have been a different outcome.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.